TuxCare Announces Extended Lifecycle Support Service for Python Programming Language
15.9.2022 03:56:00 EEST | Business Wire | Press release
TuxCare, a global innovator in enterprise-grade cybersecurity for Linux, today announced the launch and general availability of its Python Extended Lifecycle Support (ELS) service.
Often selected for artificial intelligence, machine learning, data analytics and complex websites, Python currently stands as the world’s most popular programming language. The new TuxCare Python ELS service is easily deployed and aims to breathe new life into code written for out-of-support Python versions – dramatically simplifying the life of personnel who otherwise face time-consuming tasks related to deprecated and removed functionality.
Enabling organizations to avoid any performance-related issues associated with changes, the ELS service also allows existing code to run as-is, simply on a more secure foundation that automatically receives patches for critical security vulnerabilities.
“Significantly lengthening the lifetime of your vital Python applications through a TuxCare ELS not only makes sense from a security posture perspective, but it can bring time savings and cost reductions during a time that makes a big difference for an organization,” said Jim Jackson, President and Chief Revenue Officer at TuxCare. “We often find that DevOps groups and their extended management team label TuxCare as a notable business enabler and application ROI extender that pays for itself and much more. “We’re proud to play that distinct role as the extended lifecycle innovator within a vital cybersecurity ecosphere.”
Python 2.7, which became unsupported in 2020, is fully addressed by the new TuxCare Python ELS. For more information, visit https://tuxcare.com/extended-lifecycle-support/python/.
Last month, the company also announced the launch of its new PHP ELS.
About TuxCare
TuxCare is on a mission to reduce the world’s risk of cyber exploitation. Through its automated live security patching solutions and extended lifecycle support services for Linux and open source software and languages, TuxCare allows thousands of organizations to rapidly remediate vulnerabilities for increased security and compliance. The world’s largest enterprises, government agencies, service providers, universities, and research institutions are protected by TuxCare on over one million workloads and growing. For more information, go to www.tuxcare.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220907005364/en/
Contact information
TuxCare Contact:
marketing@tuxcare.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
H2SITE Appoints Javier Cavada as New Chairman of the Board of Directors17.3.2026 08:00:00 EET | Press release
H2SITE, a technology company delivering hydrogen production and separation solutions, announces the appointment of Javier Cavada as the new Chairman of the Board of Directors. Javier joins H2SITE at a strategic phase of accelerated industrial deployment and scale-up of its hydrogen solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260316654723/en/ With more than 25 years of international leadership in the energy and industrial sectors, Javier brings extensive experience in industrialising complex technologies, building high-performance organisations, and scaling large-scale energy platforms. He currently serves as President and Chief Executive Officer of Mitsubishi Power EMEA. His track record also includes serving as CEO and President of Highview Power, as well as spending 17 years at Wärtsilä Corporation, where he held senior executive roles including President of the Energy division and a member of the global Exec
AMWC 2026: Galderma Showcases Category‑leading Innovation With a Comprehensive Portfolio and Holistic, Future‑focused Aesthetic Strategies17.3.2026 08:00:00 EET | Press release
Galderma (SIX: GALD) will present nine abstracts at the Aesthetic & Anti‑Aging Medicine (AMWC) World Congress 2026 in Monaco, showcasing innovative and robust scientific data across its aesthetics portfolio, alongside three symposia, and multiple Masterclasses and Meet‑the‑Expert sessions, all highlighting the expanding benefits of Sculptra, Relfydess and the Restylane range.1-9 This comprehensive scientific presence reflects Galderma’s holistic, trend‑led approach to innovation, and its commitment to addressing emerging needs such as menopause‑related skin changes, the growing interest in regenerative treatments, and the rising demand for body injectables. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260316497387/en/ “Patients’ needs are changing faster than ever, whether that’s navigating the skin changes associated with menopause, seeking regenerative benefits, or looking for aesthetic harmony beyond the face. The data
Fujirebio Announces CE Marking of the Fully Automated Lumipulse ® G Nfl Blood Assay17.3.2026 08:00:00 EET | Press release
H.U. Group Holdings Inc., and its wholly owned subsidiary, Fujirebio Holdings, Inc. (hereinafter “Fujirebio”) today announced that Fujirebio Europe N.V. has obtained a CE Certificate of the Lumipulse G NfL Blood assay under the Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR). This CLEIA (chemiluminescent enzyme immunoassay) test allows for the quantitative measurement of Neurofilament light chain (NfL) in plasma and serum. “While our assay menu already features many powerful disease-specific biomarkers, NfL marks a major breakthrough: our first CE-marked blood test that empowers clinicians with insights across a wide range of neurological disorders,” said Christiaan De Wilde, CEO at Fujirebio Europe N.V. “We are excited to bring this test to our customers, further expanding our comprehensive portfolio of fully automated neurological disease testing solutions on the LUMIPULSE G platform. We continue to partner with organizations and clinical experts across the wor
Miro Announces Asia Hub in Singapore to Accelerate Growth Across the Region and Bring AI Collaboration to New Markets17.3.2026 03:00:00 EET | Press release
Miro®, the AI Innovation Workspace for teams, today announced plans to expand its operations in Asia, supporting organisations across the region in their AI transformation journey. Miro is investing in people, resources, and infrastructure as it targets growth in key markets, including Singapore, India, South Korea, and other Southeast Asia countries. As the global innovation centre of gravity shifts toward Asia – where R&D spending reached 45% of global investment in 2024 – the organisations leading this charge need tools and platforms built for the complexity and pace of modern innovation and collaboration. Miro's AI-powered innovation workspace is uniquely positioned to support this moment. Miro gives organisations the shared context layer they need to move from insight to execution faster than ever before. For Asia's most ambitious innovators, where speed-to-market and cross-border collaboration are existential priorities, Miro provides the link between human creativity and AI capa
IQM and Zurich Instruments Launch Real-Time Quantum Error Correction Demonstrator with NVIDIA NVQLink16.3.2026 23:24:00 EET | Press release
Today, IQM Quantum Computers and Zurich Instruments announce a joint project to build and operate a real-time quantum error correction (QEC) demonstrator, enabled by the NVIDIA NVQLink platform. This project marks a significant milestone toward scalable and fault-tolerant quantum computing designed for enterprise and datacenter deployment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260316511715/en/ IQM and Zurich Instruments launch real-time quantum error correction demonstrator with NVIDIA NVQLink As enterprises and public institutions worldwide move from quantum exploration to long-term deployment, the challenge has evolved beyond simply accessing quantum hardware. The focus is now on reliably operating quantum computers, seamlessly integrating them into existing compute infrastructure, and scaling them toward fault tolerance. The announced project directly addresses these needs by focusing on full-system integration f
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom